Edit |   |
---|---|
Antigenic Specificity | CD22, Human (Inotuzumab biosimilar) |
Clone | Inotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD22 Recombinant Antibody (Inotuzumab). Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). |
Immunogen | n/a |
Other Names | Anti-CD22 Recombinant Antibody, Research Grade Inotuzumab, Anti-Human CD22 Recombinant Antibody(Inotuzumab), CMC-544, Antibody Drug Analogues, Monoclonal Antibody, YR1170, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 635715-01-4 |
Catalog # | YR1170 |
Price | please inquire |
Order / More Info | CD22, Human (Inotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |